word of mouth . Today , with scientific and technology innovations , market expansion , increased awareness , genomics has transformed the healthcare landscape . With advancements in disease classification and the emergence of more therapeutics , doctors are better equipped to identify and initiate appropriate treatment plans , leading to more actionable outcomes . ty , MedGenome has been consciously affordable and accessible to the orks with nonprofit organizations for search studies and provide deep disleged patients .
Unique positioning
The genetic richness of the Indian population had not been explored earlier . India ' s diverse population , with its 4500 homogeneous sub-groups practicing endogamy , consanguineous marriages presented an opportunity to understand diseases .
While the MedGenome took the advantage of being the first mover , its journey has not been very easy one as clinician acceptance was a crucial part of the business . Despite the challenges , company remained focused on the goal of educating the prescriber community while overcoming the operational challenges . Along the way there were others from the scientific and investor community who believed in its vision and wanted to support its efforts . Over the period of time , company has associated itself with a large group of scientific key opinion leaders and is the most heavily funded player in this space in India .
Mahesh Pratapneni , Co-founder , Group CEO , MedGenome says , “ While
BIOVOICENEWS . COM 15